RES 211231 Exhibit A - Laserfiche WebLink

City of Pleasanton–10x Genomics Project Introduction Initial Study/Mitigated Negative Declaration 4 FirstCarbon Solutions Https://adecinnovations.sharepoint.com/sites/PublicationsSite/Shared Documents/Publications/Client (PN-JN)/2148/21480024/ISMND/wp/21480024 10x Genomics Project Full Screencheck ISMND.docx Phase 2 Phase 2 would include construction of an R&D facility on the eastern portion of the project site (Building 2), removal of up to 600 existing surface parking stalls, and construction of a maximum 6- story parking structure. Building 2 would have up to 63,250 square feet of general administrative and office uses, and 51,750 square feet for production laboratories, for a total of up to 115,000 square feet in an up to 4-story building with a maximum height of 82 feet. The parking structure would provide 354,000 square feet for parking on a 59,000-square-foot building footprint supplying 1,168 parking stalls. Phase 3 Phase 3 would include the construction of an R&D facility on the southeastern portion of the project site (Building 3). Building 3 would have 63,834 square feet for general administrative and office uses and 52,228 square feet for production laboratories, for a total of 116,062 square feet in an up to 4- story building with a maximum height of 82 feet. A 36,000 square foot surface parking lot would be constructed south of the parking structure, providing 90 surface parking stalls. The construction of Phase 3 may occur in conjunction with the construction of Phase 2. 1.4.2 - Construction Phase 1 construction is expected to begin in Fall 2021 and would last for approximately 9.5 months. Phase 2 construction is estimated to be completed by 2025. Phase 3 is estimated to be completed by 2029. 1.4.3 - Operations The proposed project would be used for commercial, and office uses, R&D, and light laboratory manufacturing. The specific nature of the proposed uses may include highly specialized, technical activities such as R&D, small-scale assembly of instruments, consumables, and software for analyzing biological systems. Per the Applicant, these activities would occur in clean-room environments that would not involve large- or heavy industrial-scale processes or machinery. At Phase I, the proposed project would include the following uses and square footages: • 20,000 square feet would be used for packaging, warehousing, and distribution uses. • 80,000 square feet would be for general administrative and office uses. • 50,000 square feet would be used for production laboratories. At full buildout, the proposed project would include the following uses and square footages: • 20,000 square feet would be used for packaging, warehousing, and distribution uses. • 206,834 square feet would be for general administrative and office uses. • 153,978 square feet would be used for production laboratories. 1.4.4 - Site Access and Circulation Primary access to the project site would be provided from a driveway off Springdale Avenue, located along the western project boundary. A second driveway along Stoneridge Mall Road would provide